Navigation Links
Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts

The new generation stents that are deigned for slow release of medication are found to be far more effective than conventional stents according to a recent study conducted on stents used for cardiac bypass // . It is also found to effectively prevent the overgrowth of scar tissue, thereby reducing incidence of restenosis (re-narrowing), heart attack and death.

Stents can either be inserted into a grafted vein or into a native coronary artery during a balloon angioplasty procedure. The plague-clogged area is opened up by the balloon followed by which a stent is placed to keep the vessel patent.

Veins removed from the legs (saphenous veins) are used to replace clogged arteries in the heart (coronary arteries). However, these grafts become old over a period of time. Infact nearly 50% of all vein grafts become diseased, necessitating a second intervention in the form of either a repeat open-heart surgery or balloon angioplasty with a reinsertion of a stent within 5 to 10 years of first cardiac surgery.

Some of the causes for restenosis include build up of plaque, cholesterol debris and blood clots that hinder with the patency of the graft. The incidence of re-stenosis is much greater in the saphenous vein grafts compared with percutaneous interventional procedure involving the native coronary arteries. The new stents were found to reduce the risk of re-stenosis by as much as 4 times compared to commercially available stents.

Out of the 223 patients who underwent angioplasty for treatment of diseased saphenous vein grafts (placed 8 years ago), 139 patients had drug-eluting stents placed. The rest of them had conventional stents placed.

The incidence of heart attacks, the necessity to reopen a vein graft was considerably lower among those fitted with a drug eluting stent with the reduction rates approximating to 4 and 10 compared to 20 and 37 in those fitted with a conventional stent.

Previous studies have already established that medicated stents are effective in the prevention of scar tissue formation and narrowing in the coronary arteries, the study is the first of it’s kind to explore the effectiveness in saphenous vein grafts.

The researchers intend to continue the study to find if similar results would be obtained on a long-term basis.


'"/>




Related medicine news :

1. Stronger Backing for Drug-Coated Stents
2. Drug-Coated Stents – Proven to be More Effectiv
3. The Efficacy Of Newer Stents Questioned
4. Analyzing The Side Effects Of Sirolimus Stents
5. Stents That Release Medication To Check Artery Narrowing
6. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Nitiol Stents A Better Alternative for the Conventional Stents
9. Does Life Saving Stents Actually Carry The Risk Of Blood Clots?
10. Bottleneck for Neck Stents - May Enhance Risk of Stroke, Says a Study
11. Using Heart Stents Tends to Form More Clots
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology: